Ivan Ivetac

Ivan Ivetac

Auto-generated profile, based on publicly available information

Ivan Ivetac

Ruđer Bošković Institute, Center for Marine Research, G. Paliaga 5, 52 210 Rovinj, Croatia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KKKathryn M. Kinross
Kathryn M. Kinross
KMKaren G. Montgomery
Karen G. Montgomery
MKMargarete Kleinschmidt
Margarete Kleinschmidt
PWPaul Waring
Paul Waring
IIIvan Ivetac
Ivan Ivetac
WPWayne Phillips
Wayne Phillips
Mutations in the gene encoding the p110α subunit of PI3K (PIK3CA) that result in enhanced PI3K activity are frequently observed in human cancers. To better understand the role of mutant PIK3CA in the initiation or progression of tumorigenesis, we generated mice in which a PIK3CA mutation commonly detected in human cancers (the H1047R mutation) could be conditionally knocked into the endogenous Pik3ca locus. Activation of this mutation in the mouse ovary revealed that alone, Pik3caH1047R induced premalignant hyperplasia of the ovarian surface epithelium but no tumors. Concomitantly, we analyzed several human ovarian cancers and found PIK3CA mutations coexistent with KRAS and/or PTEN mutations, raising the possibility that a secondary defect in a co-regulator of PI3K activity may be required for mutant PIK3CA to promote transformation. Consistent with this notion, we found that Pik3caH1047R mutation plus Pten deletion in the mouse ovary led to the development of ovarian serous adenocarcinomas and granulosa cell tumors. Both mutational events were required for early, robust Akt activation. Pharmacological inhibition of PI3K/mTOR in these mice delayed tumor growth and prolonged survival. These results demonstrate that the Pik3caH1047R mutation with loss of Pten is enough to promote ovarian cell transformation and that we have developed a model system for studying possible therapies.

1 May 2005 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
IIIvan Ivetac
Ivan Ivetac
AMAdam D. Munday
Adam D. Munday
MKMarina V. Kisseleva
Marina V. Kisseleva
XZXiang-Ming Zhang
Xiang-Ming Zhang
SLSusan Luff
Susan Luff
CMChristina A. Mitchell
Christina A. Mitchell
Endosomal trafficking is regulated by the recruitment of effector proteins to phosphatidylinositol 3-phosphate [PtdIns(3)P] on early endosomes. At the plasma membrane, phosphatidylinositol-(3,4)-bisphosphate [PtdIns(3,4)P2] binds the pleckstrin homology (PH) domain-containing proteins Akt and TAPP1. Type Iα inositol polyphosphate 4-phosphatase (4-phosphatase) dephosphorylates PtdIns(3,4)P2, forming PtdIns(3)P, but its subcellular localization is unknown. We report here in quiescent cells, the 4-phosphatase colocalized with early and recycling endosomes. On growth factor stimulation, 4-phosphatase endosomal localization persisted, but in addition the 4-phosphatase localized at the plasma membrane. Overexpression of the 4-phosphatase in serum-stimulated cells increased cellular PtdIns(3)P levels and prevented wortmannin-induced endosomal dilatation. Furthermore, mouse embryonic fibroblasts from homozygous Weeble mice, which have a mutation in the type I 4-phosphatase, exhibited dilated early endosomes. 4-Phosphatase translocation to the plasma membrane upon growth factor stimulation inhibited the recruitment of the TAPP1 PH domain. The 4-phosphatase contains C2 domains, which bound PtdIns(3,4)P2, and C2-domain-deletion mutants lost PtdIns(3,4)P24-phosphatase activity, did not localize to endosomes or inhibit TAPP1 PH domain membrane recruitment. The 4-phosphatase therefore both generates and terminates phosphoinositide 3-kinase signals at distinct subcellular locations.

27 March 2009 in EMBO Reports
Verified
Journal Article
Open access
PDF file
IIIvan Ivetac
Ivan Ivetac
RGRajendra Gurung
Rajendra Gurung
SHSandra Hakim
Sandra Hakim
KHKristy A Horan
Kristy A Horan
DSDavid A Sheffield
David A Sheffield
CMChristina A. Mitchell
Christina A. Mitchell
Akt is a crucial phosphoinositide 3‐kinase (PI(3)K) effector that regulates cell proliferation and survival. PI(3)K‐generated signals, PtdIns(3,4,5)P3 and PtdIns(3,4)P2, direct Akt plasma membrane engagement. Pathological Akt plasma membrane association promotes oncogenesis. PtdIns(3,4)P2 is degraded by inositol polyphosphate 4‐phosphatase‐1 (4‐ptase‐1) forming PtdIns(3)P; however, the role of 4‐ptase‐1 in regulating the activation and function of Akt is unclear. In mouse embryonic fibroblasts lacking 4‐ptase‐1 (−/−MEFs), the Akt‐pleckstrin homology (PH) domain was constitutively membrane‐associated both in serum‐starved and agonist‐stimulated cells, in contrast to +/+MEFs, in which it was detected only at the plasma membrane following serum stimulation. Epidermal growth factor (EGF) stimulation resulted in increased Ser473 and Thr308‐Akt phosphorylation and activation of Akt‐dependent signalling in −/−MEFs, relative to +/+MEFs. Significantly, loss of 4‐ptase‐1 resulted in increased cell proliferation and decreased apoptosis. SV40‐transformed −/−MEFs showed increased anchorage‐independent cell growth and formed tumours in nude mice. This study provides the first evidence, to our knowledge, that 4‐ptase‐1 controls the activation of Akt and thereby cell proliferation, survival and tumorigenesis.

30 May 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ATAnjali Tikoo
Anjali Tikoo
VRVincent Roh
Vincent Roh
KMKaren G. Montgomery
Karen G. Montgomery
IIIvan Ivetac
Ivan Ivetac
PWPaul Waring
Paul Waring
WPWayne Phillips
Wayne Phillips
PIK3CA, the gene coding for the p110α subunit of phosphoinositide 3-kinase, is frequently mutated in a variety of human tumors including breast cancers. To better understand the role of mutant PIK3CA in the initiation and/or progression of breast cancer, we have generated mice with a conditional knock-in of the common activating mutation, Pik3caH1047R, into one allele of the endogenous gene in the mammary gland. These mice developed a ductal anaplasia and hyperplasia by 6 weeks of age characterized by multi-layering of the epithelial lining of the mammary ducts and expansion of the luminal progenitor (Lin−; CD29lo; CD24+; CD61+) cell population. The Pik3caH1047R expressing mice eventually develop mammary tumors with 100% penetrance but with a long latency (>12 months). This is significantly longer than has been reported for transgenic models where expression of the mutant Pik3ca is driven by an exogenous promoter. Histological analysis of the tumors formed revealed predominantly ERα-positive fibroadenomas, carcinosarcomas and sarcomas. In vitro induction of Pik3caH1047R in immortalized mammary epithelial cells also resulted in tumor formation when injected into the mammary fat pad of immunodeficient recipient mice. This novel model, which reproduces the scenario of a heterozygous somatic mutation occurring in the endogenous PIK3CA gene, will thus be a valuable tool for investigating the role of Pik3caH1047R mutation in mammary tumorigenesis both in vivo and in vitro.

1 February 2006 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
LOLisa M. Ooms
Lisa M. Ooms
CFClare G. Fedele
Clare G. Fedele
MAMegan V. Astle
Megan V. Astle
IIIvan Ivetac
Ivan Ivetac
VCVanessa Cheung
Vanessa Cheung
CMChristina A. Mitchell
Christina A. Mitchell
The spatial activation of phosphoinositide 3-kinase (PI3-kinase) signaling at the axon growth cone generates phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3), which localizes and facilitates Akt activation and stimulates GSK-3β inactivation, promoting microtubule polymerization and axon elongation. However, the molecular mechanisms that govern the spatial down-regulation of PtdIns(3,4,5)P3signaling at the growth cone remain undetermined. The inositol polyphosphate 5-phosphatases (5-phosphatase) hydrolyze the 5-position phosphate from phosphatidylinositol 4,5 bisphosphate (PtdIns(4,5)P2) and/or PtdIns(3,4,5)P3. We demonstrate here that PIPP, an uncharacterized 5-phosphatase, hydrolyzes PtdIns(3,4,5)P3forming PtdIns(3,4)P2, decreasing Ser473-Akt phosphorylation. PIPP is expressed in PC12 cells, localizing to the plasma membrane of undifferentiated cells and the neurite shaft and growth cone of NGF-differentiated neurites. Overexpression of wild-type, but not catalytically inactive PIPP, in PC12 cells inhibited neurite elongation. Targeted depletion of PIPP using RNA interference (RNAi) resulted in enhanced neurite differentiation, associated with neurite hyperelongation. Inhibition of PI3-kinase activity prevented neurite hyperelongation in PIPP-deficient cells. PIPP targeted-depletion resulted in increased phospho-Ser473-Akt and phospho-Ser9-GSK-3β, specifically at the neurite growth cone, and accumulation of PtdIns(3,4,5)P3at this site, associated with enhanced microtubule polymerization in the neurite shaft. PIPP therefore inhibits PI3-kinase-dependent neurite elongation in PC12 cells, via regulation of the spatial distribution of phospho-Ser473-Akt and phospho-Ser9-GSK-3β signaling.

31 October 2018 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
Werner E.G. MüllerWerner E.G. Müller
Werner E.G. Müller
MAMaximilian Ackermann
Maximilian Ackermann
ETEmad Tolba
Emad Tolba
Meik NeufurthMeik Neufurth
Meik Neufurth
IIIvan Ivetac
Ivan Ivetac
Xiaohong WANGXiaohong WANG
Xiaohong WANG
The in vitro tube formation assay with human umbilical vein endothelial cells (HUVEC) was applied to identify the extra- and intracellular sources of metabolic energy/ATP required for cell migration during the initial stage of microvascularization. Extracellularly, the physiological energy-rich polymer, inorganic polyphosphate (polyP), applied as biomimetic amorphous calcium polyP microparticles (Ca-polyP-MP), is functioning as a substrate for ATP generation most likely via the combined action of the alkaline phosphatase (ALP) and the adenylate kinase (AK). The linear Ca-polyP-MP with a size of 40 phosphate units, close to the polyP in the acidocalcisomes in the blood platelets, were found to increase endothelial cell tube formation, as well as the intracellular ATP levels. Depletion of extracellular ATP with apyrase suppressed tube formation during the initial incubation period. Inhibition experiments revealed that inhibitors (levamisole and Ap5A) of the enzymes involved in extracellular ATP generation strongly reduce the Ca-polyP-MP-induced tube formation. The stimulatory effect of Ca-polyP-MP was also diminished by the glycolysis inhibitor oxamate and trifluoperazine which blocks endocytosis, as well as by MRS2211, an antagonist of the P2Y13 receptor. Oligomycin, an inhibitor of the mitochondrial F0F1-ATP synthase, displayed no effect at lower concentrations on tube formation. Electron microscopic data revealed that after cellular uptake, the Ca-polyP-MP accumulate close to the cell membrane. We conclude that in HUVEC exposed to polyP, ATP is formed extracellularly via the coupled ALP-AK reaction, and intracellularly during glycolysis. The results suggest an autocrine signaling pathway of ATP with polyP as an extracellular store of metabolic energy for endothelial cell migration during the initial vascularization process.